Abstracts of the 3(rd) Annual Scientific Meeting Indonesian Heart Rhythm Society, October 23 – 24, 2015

Background: Previous meta-analysis (Capodanno D, et al, 2012) concluded that in patients with non-valvular atrial fibrillation (NVAF) in world patients, novel oral anticoagulants (NOACs) significantly decreased incidences of all type of stroke and systemic embolism (SE) with similar risk of major bl...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: ASEAN Federation of Cardiology 2015
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4685986/
https://www.ncbi.nlm.nih.gov/pubmed/26709374
http://dx.doi.org/10.7603/s40602-015-0004-x
Descripción
Sumario:Background: Previous meta-analysis (Capodanno D, et al, 2012) concluded that in patients with non-valvular atrial fibrillation (NVAF) in world patients, novel oral anticoagulants (NOACs) significantly decreased incidences of all type of stroke and systemic embolism (SE) with similar risk of major bleeding compared to warfarin. But, it is unknown about efficacy and safety of NOACs compared to warfarin in East-Southeast Asian population.

Ejemplares similares